FDA Import Refusal AEK-4969002-4/11/1 — CIPLA LTD
The FDA refused shipment AEK-4969002-4/11/1 from CIPLA LTD (India) on Jul 27, 2018. The refused product falls under Drugs and Biologics — ATORVASTATIN CALCIUM (ANTI-CHOLESTEREMIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Jul 27, 2018
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61JDY08 ATORVASTATIN CALCIUM (ANTI-CHOLESTEREMIC)
- Charges
- 75